Registry Study of Proton Radiotherapy in Lymphoma

Recruiting now

Conditions studied: Mediastinal Lymphoma

In brief

The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.

Key facts

Study ID

NCT04613388

Run by

University Hospital Heidelberg

People needed

200

Starts

2018-08-01

Expected to finish

2031-08-01

Last updated by the study team

2026-04-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed lymphoma according to WHO
• Patient consent
• Patient age ≥18 years.
• Presence of the need for mediastinal radiotherapy and the presumed benefit of mediastinal radiotherapy using protons in comparison to photon radiation (e.g. improved heart, lungs, and breast protection compared to photon radiation).
• Ability of the patient to give consent

You may not qualify if…

• Age <18 years
• Non-consent of the patient to the disclosure of his data
• Cancellation of the patient's participation in the study

Where it is running

• University Hospital Heidelberg — Heidelberg, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.